D W Kim1. 1. Department of Radiology, Busan Paik Hospital, Inje University College of Medicine, Busan, South Korea. dwultra@lycos.co.kr
Abstract
BACKGROUND AND PURPOSE: No study has previously examined the feasibility of using EA to remove any peripherally located, solid components remaining after treatment of benign solid thyroid nodules by RFA. The aim of this study was to assess the efficacy of EA in removing remnant solid components following the incomplete ablation of benign solid thyroid nodules by RFA. MATERIALS AND METHODS: During a 1-year period, RFA was performed in 18 benign solid thyroid nodules in 17 patients. EA was subsequently performed on 8 of these nodules. The success rate of EA, size and vascularity of the remaining solid components, amount of injected ethanol, degree of intranodular echo staining just after ethanol injection, and number of EA sessions were assessed. RESULTS: Of 18 post-RFA nodules, 8 nodules were subsequently treated with EA because of incomplete ablation, as defined by the presence of peripherally located vascularized solid components. On follow-up US, 2 nodules showed marked hypoechogenicity and no vascularity of the remaining solid components, while 3 nodules showed considerably decreased echogenicity and vascularity of the remaining solid components. Three nodules showed no significant decrease or mild decrease in the echogenicity and vascularity of the remaining solid components. No serious complications were observed during or after RFA or EA, with the exception of 1 patient who experienced diffuse glandular hemorrhage during these procedures. CONCLUSIONS: EA was effectively used to remove incompletely ablated components of benign solid thyroid nodules remaining after RFA.
BACKGROUND AND PURPOSE: No study has previously examined the feasibility of using EA to remove any peripherally located, solid components remaining after treatment of benign solid thyroid nodules by RFA. The aim of this study was to assess the efficacy of EA in removing remnant solid components following the incomplete ablation of benign solid thyroid nodules by RFA. MATERIALS AND METHODS: During a 1-year period, RFA was performed in 18 benign solid thyroid nodules in 17 patients. EA was subsequently performed on 8 of these nodules. The success rate of EA, size and vascularity of the remaining solid components, amount of injected ethanol, degree of intranodular echo staining just after ethanol injection, and number of EA sessions were assessed. RESULTS: Of 18 post-RFA nodules, 8 nodules were subsequently treated with EA because of incomplete ablation, as defined by the presence of peripherally located vascularized solid components. On follow-up US, 2 nodules showed marked hypoechogenicity and no vascularity of the remaining solid components, while 3 nodules showed considerably decreased echogenicity and vascularity of the remaining solid components. Three nodules showed no significant decrease or mild decrease in the echogenicity and vascularity of the remaining solid components. No serious complications were observed during or after RFA or EA, with the exception of 1 patient who experienced diffuse glandular hemorrhage during these procedures. CONCLUSIONS: EA was effectively used to remove incompletely ablated components of benign solid thyroid nodules remaining after RFA.
Authors: Dong Wook Kim; Myung Ho Rho; Hak Jin Kim; Jae Su Kwon; Young Sun Sung; Sang Wook Lee Journal: AJNR Am J Neuroradiol Date: 2005-09 Impact factor: 3.825
Authors: F Monzani; N Caraccio; O Goletti; P V Lippolis; A Casolaro; P Del Guerra; E Cavina; P Miccoli Journal: Clin Endocrinol (Oxf) Date: 1997-01 Impact factor: 3.478
Authors: E Papini; C Panunzi; C M Pacella; G Bizzarri; R Fabbrini; L Petrucci; G Pisicchio; F Nardi Journal: J Clin Endocrinol Metab Date: 1993-02 Impact factor: 5.958
Authors: Antonio Barile; Simone Quarchioni; Federico Bruno; Anna Maria Ierardi; Francesco Arrigoni; Aldo Victor Giordano; Sergio Carducci; Marco Varrassi; Giampaolo Carrafiello; Ferdinando Caranci; Alessandra Splendiani; Ernesto Di Cesare; Carlo Masciocchi Journal: Gland Surg Date: 2018-04